Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder

por Lee, Young H., Lee, Molly M., De Silva, Dinuka M., Roy, Arpita, Wright, Cara E., Wong, Tiffany K., Costello, Rene, Olaku, Oluwole, Grubb, Robert L., Agarwal, Piyush K., Apolo, Andrea B., Bottaro, Donald P.
Publicado 2021

Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors

por Nikolos, Fotis, Hayashi, Kazukuni, Hoi, Xen Ping, Alonzo, Mark Ellie, Mo, Qianxing, Kasabyan, Armine, Furuya, Hideki, Trepel, Jane, Di Vizio, Dolores, Guarnerio, Jlenia, Theodorescu, Dan, Rosser, Charles, Apolo, Andrea, Galsky, Matthew, Chan, Keith Syson
Publicado 2022

Failure-free survival of the Riata implantable cardioverter-defibrillator lead after a very long-term follow-up

por San Antonio, Rodolfo, Guasch, Eduard, Chipa-Ccasani, Fredy, Apolo, José, Pujol-López, Margarida, Fernández, Hael, Trotta, Omar, Niebla, Mireia, Borràs, Roger, Trucco, Emilce, Arbelo, Elena, Roca-Luque, Ivo, Brugada, Josep, Mont, Lluís, Tolosana, José María
Publicado 2019

Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder

por McNeil, Brian K, Sorbellini, Maximiliano, Grubb, Robert L, Apolo, Andrea, Cecchi, Fabiola, Athauda, Gagani, Cohen, Benjamin, Giubellino, Alessio, Simpson, Haley, Agarwal, Piyush K, Coleman, Jonathan, Getzenberg, Robert H, Netto, George J, Shih, Joanna, Linehan, W Marston, Pinto, Peter A, Bottaro, Donald P
Publicado 2014

Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

por Apolo, Andrea B., Infante, Jeffrey R., Balmanoukian, Ani, Patel, Manish R., Wang, Ding, Kelly, Karen, Mega, Anthony E., Britten, Carolyn D., Ravaud, Alain, Mita, Alain C., Safran, Howard, Stinchcombe, Thomas E., Srdanov, Marko, Gelb, Arnold B., Schlichting, Michael, Chin, Kevin, Gulley, James L.
Publicado 2017

(18)F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab

por Lim, Ilhan, Lindenberg, Maria Liza, Mena, Esther, Verdini, Nicholas, Shih, Joanna H., Mayfield, Christian, Thompson, Ryan, Lin, Jeffrey, Vega, Andy, Mallek, Marissa, Cadena, Jacqueline, Diaz, Carlos, Mortazavi, Amir, Knopp, Michael, Wright, Chadwick, Stein, Mark, Pal, Sumanta, Choyke, Peter L., Apolo, Andrea B.
Publicado 2019

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

por Apolo, Andrea B, Ellerton, John A, Infante, Jeffrey R, Agrawal, Manish, Gordon, Michael S, Aljumaily, Raid, Gourdin, Theodore, Dirix, Luc, Lee, Keun-Wook, Taylor, Matthew H, Schöffski, Patrick, Wang, Ding, Ravaud, Alain, Manitz, Juliane, Pennock, Gregory, Ruisi, Mary, Gulley, James L, Patel, Manish R
Publicado 2020

Genetic Variant as a Selection Marker for Anti–Prostate Stem Cell Antigen Immunotherapy of Bladder Cancer

por Kohaar, Indu, Porter-Gill, Patricia, Lenz, Petra, Fu, Yi-Ping, Mumy, Adam, Tang, Wei, Apolo, Andrea B., Rothman, Nathaniel, Baris, Dalsu, Schned, Alan R., Ylaya, Kris, Schwenn, Molly, Johnson, Alison, Jones, Michael, Kida, Masatoshi, Silverman, Debra T., Hewitt, Stephen M., Moore, Lee E., Prokunina-Olsson, Ludmila
Publicado 2013

Legal and ethical framework for global health information and biospecimen exchange - an international perspective

por Bernasconi, Lara, Şen, Selçuk, Angerame, Luca, Balyegisawa, Apolo P., Hong Yew Hui, Damien, Hotter, Maximilian, Hsu, Chung Y., Ito, Tatsuya, Jörger, Francisca, Krassnitzer, Wolfgang, Phillips, Adam T., Li, Rui, Stockley, Louise, Tay, Fabian, von Heijne Widlund, Charlotte, Wan, Ming, Wong, Creany, Yau, Henry, Hiemstra, Thomas F., Uresin, Yagiz, Senti, Gabriela
Publicado 2020

Predicting cancer immunotherapy response from gut microbiomes using machine learning models

por Liang, Hai, Jo, Jay-Hyun, Zhang, Zhiwei, MacGibeny, Margaret A., Han, Jungmin, Proctor, Diana M., Taylor, Monica E., Che, You, Juneau, Paul, Apolo, Andrea B., McCulloch, John A., Davar, Diwakar, Zarour, Hassane M., Dzutsev, Amiran K., Brownell, Isaac, Trinchieri, Giorgio, Gulley, James L., Kong, Heidi H.
Publicado 2022

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome

por Dinstag, Gal, Shulman, Eldad D., Elis, Efrat, Ben-Zvi, Doreen S., Tirosh, Omer, Maimon, Eden, Meilijson, Isaac, Elalouf, Emmanuel, Temkin, Boris, Vitkovsky, Philipp, Schiff, Eyal, Hoang, Danh-Tai, Sinha, Sanju, Nair, Nishanth Ulhas, Lee, Joo Sang, Schäffer, Alejandro A., Ronai, Ze’ev, Juric, Dejan, Apolo, Andrea B., Dahut, William L., Lipkowitz, Stanley, Berger, Raanan, Kurzrock, Razelle, Papanicolau-Sengos, Antonios, Karzai, Fatima, Gilbert, Mark R., Aldape, Kenneth, Rajagopal, Padma S., Beker, Tuvik, Ruppin, Eytan, Aharonov, Ranit
Publicado 2023

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

por Girardi, Daniel M., Niglio, Scot A., Mortazavi, Amir, Nadal, Rosa, Lara, Primo, Pal, Sumanta K., Saraiya, Biren, Cordes, Lisa, Ley, Lisa, Ortiz, Olena Sierra, Cadena, Jacqueline, Diaz, Carlos, Bagheri, Hadi, Redd, Bernadette, Steinberg, Seth M., Costello, Rene, Chan, Keith S., Lee, Min-Jung, Lee, Sunmin, Yu, Yunkai, Gurram, Sandeep, Chalfin, Heather J., Valera, Vladimir, Figg, William D., Merino, Maria, Toubaji, Antoun, Streicher, Howard, Wright, John J., Sharon, Elad, Parnes, Howard L., Ning, Yang-Min, Bottaro, Donald P., Cao, Liang, Trepel, Jane B., Apolo, Andrea B.
Publicado 2022

Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer

por Lerner, Seth P., Bajorin, Dean F., Dinney, Colin P., Efstathiou, Jason A., Groshen, Susan, Hahn, Noah M., Hansel, Donna, Kwiatkowski, David, O’Donnell, Michael, Rosenberg, Jonathan, Svatek, Robert, Abrams, Jeffrey S., Al-Ahmadie, Hikmat, Apolo, Andrea B., Bellmunt, Joaquim, Callahan, Margaret, Cha, Eugene K., Drake, Charles, Jarow, Jonathan, Kamat, Ashish, Kim, William, Knowles, Margaret, Mann, Bhupinder, Marchionni, Luigi, McConkey, David, McShane, Lisa, Ramirez, Nilsa, Sharabi, Andrew, Sharpe, Arlene H., Solit, David, Tangen, Catherine M., Amiri, Abdul Tawab, Van Allen, Eliezer, West, Pamela J., Witjes, J. A., Quale, Diane Zipursky
Publicado 2016

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

por Apolo, Andrea B., Nadal, Rosa, Girardi, Daniel M., Niglio, Scot A., Ley, Lisa, Cordes, Lisa M., Steinberg, Seth M., Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Mallek, Marissa, Davarpanah, Nicole N., Costello, Rene, Trepel, Jane B., Lee, Min-Jung, Merino, Maria J., Bagheri, Mohammad Hadi, Monk, Paul, Figg, William D., Gulley, James L., Agarwal, Piyush K., Valera, Vladimir, Chalfin, Heather J., Jones, Jennifer, Streicher, Howard, Wright, John J., Ning, Yangmin M., Parnes, Howard L., Dahut, William L., Bottaro, Donald P., Lara, Primo N., Saraiya, Biren, Pal, Sumanta K., Stein, Mark N., Mortazavi, Amir
Publicado 2020

MPA(PASS) software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays

por Welsh, Joshua A., Killingsworth, Bryce, Kepley, Julia, Traynor, Tim, Cook, Sean, Savage, Jason, Marte, Jenn, Lee, Min-Jung, Maeng, Hoyoung M., Pleet, Michelle L., Magana, Setty, Gorgens, André, Maire, Cecile L., Lamszus, Katrin, Ricklefs, Franz L., Merino, Maria J., Linehan, W. Marston, Greten, Tim, Cooks, Tomer, Harris, Curtis C., Apolo, Andrea, Abdel-Mageed, Asim, Ivanov, Alexander R., Trepel, Jane B., Roth, Matthew, Tkach, Mercedes, Milosavljevic, Aleksandar, Théry, Clotilde, LeBlanc, Amy, Berzofsky, Jay A., Ruppin, Eytan, Aldape, Kenneth, Camphausen, Kevin, Gulley, James L., Ghiran, Ionita, Jacobson, Steve, Jones, Jennifer C.
Publicado 2022

Dynamics of disease characteristics and clinical management of critically ill COVID-19 patients over the time course of the pandemic: an analysis of the prospective, international,...

por Wendel-Garcia, Pedro David, Moser, André, Jeitziner, Marie-Madlen, Aguirre-Bermeo, Hernán, Arias-Sanchez, Pedro, Apolo, Janina, Roche-Campo, Ferran, Franch-Llasat, Diego, Kleger, Gian-Reto, Schrag, Claudia, Pietsch, Urs, Filipovic, Miodrag, David, Sascha, Stahl, Klaus, Bouaoud, Souad, Ouyahia, Amel, Fodor, Patricia, Locher, Pascal, Siegemund, Martin, Zellweger, Nuria, Cereghetti, Sara, Schott, Peter, Gangitano, Gianfilippo, Wu, Maddalena Alessandra, Alfaro-Farias, Mario, Vizmanos-Lamotte, Gerardo, Ksouri, Hatem, Gehring, Nadine, Rezoagli, Emanuele, Turrini, Fabrizio, Lozano-Gómez, Herminia, Carsetti, Andrea, Rodríguez-García, Raquel, Yuen, Bernd, Weber, Anja Baltussen, Castro, Pedro, Escos-Orta, Jesus Oscar, Dullenkopf, Alexander, Martín-Delgado, Maria C., Aslanidis, Theodoros, Perez, Marie-Helene, Hillgaertner, Frank, Ceruti, Samuele, Franchitti Laurent, Marilene, Marrel, Julien, Colombo, Riccardo, Laube, Marcus, Fogagnolo, Alberto, Studhalter, Michael, Wengenmayer, Tobias, Gamberini, Emiliano, Buerkle, Christian, Buehler, Philipp K., Keiser, Stefanie, Elhadi, Muhammed, Montomoli, Jonathan, Guerci, Philippe, Fumeaux, Thierry, Schuepbach, Reto A., Jakob, Stephan M., Que, Yok-Ai, Hilty, Matthias Peter
Publicado 2022